Condition: Hypertension · Sponsor: SoniVie Inc.
The primary objective of the THRIVE Pivotal study is to demonstrate the adjunctive effectiveness and the safety of the TIVUS system in: 1. subjects with uncontrolled hypertension (HTN) receiving 0 - 2 anti-hypertensive drugs of different classes in whom the anti-hypertensive medications will be stopped for a 4-week wash-out period before RDN/Sham procedure and during 2 months after procedure. 2. subjects with controlled hypertension receiving 1 - 2 anti-hypertensive drugs of different classes and who accept to be off-medications for a 4-week wash-out period before RDN/Sham procedure and 2 months after the procedure
This description comes directly from the study's public registry record.
Lisa Melchior · 651-324-4931 · lisa.melchior@bsci.com
Janelle Noble · 612-598-4368 · janelle.noble@bsci.com
Always discuss trial participation with your own doctor first.
| Cardiology, PC | Birmingham, Alabama, United States | Recruiting |
| Honor Health Research Institue | Scottsdale, Arizona, United States | Recruiting |
| St. Bernard's Medical Center | Jonesboro, Arkansas, United States | Recruiting |
| Arkansas Heart Hospital | Little Rock, Arkansas, United States | Recruiting |
| Cedar-Sinai Medical Center | Los Angeles, California, United States | Recruiting |
| Stanford University | Palo Alto, California, United States | Recruiting |
| Bridgeport | Bridgeport, Connecticut, United States | Recruiting |
| Ascension- Sacred Heart | Pensecola, Florida, United States | Recruiting |
| University of South Florida | Tampa, Florida, United States | Recruiting |
| Ascension Alexian Brothers | Elk Grove Village, Illinois, United States | Recruiting |
| St. John's Prairie Heart | Springfield, Illinois, United States | Recruiting |
| Southern Illinois University, School of Medicine | Springfield, Illinois, United States | Recruiting |
+ 38 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06559891